CD52-directed Cytolytic Antibody [EPC] - N0000175659

Name: Table of NDC products with cd52-directed cytolytic antibody
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000175659
Pharmacologic Name	CD52-directed Cytolytic Antibody
Pharmacologic Uses	CD52-directed cytolytic monoclonal antibody
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with CD52-directed Cytolytic Antibody

The table contains 2 products whose active ingredient are classified under the same pharmacologic class CD52-directed Cytolytic Antibody [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	58468-0200	Lemtrada	Non-Proprietary Name: Alemtuzumab	Injection, Solution, Concentrate	Intravenous	Genzyme Corporation	ACTIVE
	58468-0357	Campath	Non-Proprietary Name: Alemtuzumab	Injection	Intravenous	Genzyme Corporation	ACTIVE